source
- Novo Nordisk CEO says innovation is essential as pipeline faces setbacksDuring Novo Nordisk's second-quarter earnings call, CEO Maziar Mike Doustdar said that failure is a normal part of drug development and emphasized that the company's survival depends on continual i…
- Expedition Therapeutics raises $115M Series B for China-sourced COPD candidateExpedition Therapeutics, a US biotech, announced a $115 million Series B financing round. The capital will be used to advance its COPD drug candidate that is being developed from a China-sourced p…